Skip to main content

Day: May 27, 2020

UAB „Metalo meistrai“ įrodė savo gaminamų konstrukcijų kokybę

AB „Panevėžio statybos trestas“ įmonių grupės dukterinė įmonė UAB „Metalo meistrai“ iš kompanijos Strängbetong AB yra gavusi ieškinį 27 mln. SEK sumai (apytiksliai lygią 2 800 tūkst. eurų 2019 m. gruodžio 31 d.) Ieškinys grindžiamas teiginiu, kad Bendrovė klientui pristatė prekes su trūkumais. Vadovybė atlikusi techninę ekspertizę mano, kad kliento ieškinys neturi pagrindo. Byla buvo pradėta svarstyti Švedijos Arbitražo teisme 2020 m. pradžioje.2020 m. gegužės 26 d. Švedijoje vykęs ad hoc arbitražas paskelbė savo sprendimą, kuriuo buvo užbaigtas net dvejus metus vykęs ginčas dėl UAB „Metalo meistrai“ pristatytos produkcijos kokybės Švedijos bendrovei AB Strängbetong. Švedijos arbitražas pilna apimtimi atmetė AB Strängbetong reikalavimą ir pripažino jį kaip nepagrįstą, nes UAB „Metalo meistrai“ produkcija buvo tinkama ir kokybiška.Džiaugiamės...

Continue reading

iQSTEL’s Subsidiary IoT Labs MX Adds GSM Network and GPS Tracking Support to the New Generation of IoT Smart Gas Field Devices

NEW YORK, NY, May 27, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — iQSTEL Inc. (OTC: IQST), a leading-edge 21st Century Enhanced Telecommunications Service Provider, is pleased to announce IoT Labs MX www.iotlabs.mx, a subsidiary, has completed the circuit board upgrades for the new generation of the IoT (Internet of Things) Smart Gas field devices.The original IoT Smart Gas platform was limited to the Sigfox communications infrastructure for IoT devices. Our in-house development team has completed the communications board upgrade for the new generation of IoT Smart Gas field devices, allowing for GSM network communications, expanding the potential usage locations of the IoT Smart Gas platform. In addition, we have incorporated Geo-location using standard GPS systems.All components of the IoT Smart Gas platform, IoT field devices,...

Continue reading

VELCAN HOLDINGS: NOTICE OF ANNUAL GENERAL MEETING ON 29th JUNE 2020

PRESS RELEASELuxembourg, 27th May 2020VELCAN HOLDINGS: NOTICE OF ANNUAL GENERAL MEETINGON 29th JUNE 2020VELCAN HOLDINGS announces to the shareholders of the Company that the Annual Ordinary General meeting will be held on Monday the 29th of June 2020, at 10 a.m., in the offices of the law firm Tabery & Wauthier, 10 rue Pierre d’Aspelt, L‐1142 Luxembourg, in order to vote on the approval of the 2019 annual financial statements and condensed non-audited consolidated financial statements and on the renewal of the Board of Directors members and of the Auditor.All required information and related documents will be available for downloading on the company’s website on 27th May 2020:Notice of the Annual Ordinary General meeting;Board of Directors’ report on the resolutions proposed to the General Meeting;Text of the proposed resolutions;Single...

Continue reading

VELCAN HOLDINGS: CONVOCATION DE L’ASSEMBLEE GENERALE ANNUELLE LE 29 JUIN 2020

 COMMUNIQUE DE PRESSELuxembourg, le 27 mai 2020VELCAN HOLDINGS: CONVOCATION DE L’ASSEMBLEE GENERALEANNUELLE LE 29 JUIN 2020VELCAN HOLDINGS annonce que les actionnaires de la Société sont convoqués en Assemblée Générale Ordinaire Annuelle le lundi 29 juin 2020 à 10 heures, dans les locaux de l’Etude Tabery & Wauthier, 10 rue Pierre d’Aspelt, L‐1142 Luxembourg, à l’effet de délibérer sur l’approbation des comptes annuels et des comptes consolidés condensés non audités de l’exercice 2019 et sur le renouvellement du mandat des administrateurs et du réviseur d’entreprises agréé.L’ensemble des informations et documents requis sera mis en ligne et disponible en téléchargement libre sur le site de la Société dans la journée du 27 mai 2020 :Avis de convocation des actionnaires à l’Assemblée Générale Ordinaire;Rapport du Conseil d’Administration...

Continue reading

Pivotal Phase III trial of abaloparatide-SC in Japanese women and men with osteoporosis achieves primary endpoint

Radius partner Teijin Pharma has submitted a New Drug Application for abaloparatide-SC for treatment of osteoporosis in Japan  WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS), today announced that its partner, Teijin Pharma Limited, has submitted a New Drug Application for abaloparatide-SC in Japan for the treatment of osteoporosis in patients who are at high risk for fractures.The application is based on the positive results of the Phase III clinical study of abaloparatide-SC in Japan which included osteoporosis patients at high risk for fracture. The study achieved its efficacy endpoint with a significant increase in lumbar spine bone mineral density at 18 months and showed an acceptable safety profile. Detailed results of this trial are planned to be presented at...

Continue reading

ArcelorMittal publishes 2019 integrated annual review

 27 May 2020 – ArcelorMittal (‘the Company’), the world’s leading steel and mining company, has today published its 2019 integrated annual review, ‘Inventing smarter steels for a better world’. The review, which can be accessed at https://corporate.arcelormittal.com/corporate-library/reporting-hub/integrated-annual-review-2019, underpins the Company’s commitment to transparent reporting. It has been produced in-line with the International Integrated Reporting Council’s framework and demonstrates the Company’s approach to ensuring it brings long-term, sustainable value to its broad stakeholder base.

Continue reading

Kemira Oyj: Announcement of manager’s transaction; Wolfgang Büchele, Member of the Board, has sold 97,000 Kemira shares

Kemira OyjManagers’ transactionsMay 27, 2020 at 12.00 pm (CET+1)Kemira Oyj: Announcement of manager’s transaction; Wolfgang Büchele, Member of the Board, has sold 97,000 Kemira sharesLEI: 74370031Y7RK5H88CQ48Notification type: INITIAL NOTIFICATIONReference number: 74370031Y7RK5H88CQ48_20200527092355_2____________________________________________Transaction date: 2020-05-26Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrument type: SHAREISIN: FI0009004824Nature of the transaction: DISPOSALTransaction details(1): Volume: 97,000 Unit price: 11,2049 EURAggregated transactions(1): Volume: 97,000 Volume weighted average price: 11,2049 EURTotal ownership of instrument after the transaction: 12 632 sharesFor more information, please contact:Kemira OyjMikko Pohjala, Vice President, Investor RelationsTel.  +358 40 838 0709  Kemira is a global chemicals...

Continue reading

Kemira Oyj: Ilmoitus johtohenkilön liiketoimesta; hallituksen jäsen Wolfgang Büchele on myynyt 97 000 Kemiran osaketta

Kemira OyjJohtohenkilöiden liiketoimet27.5.2020 klo 12.00Kemira Oyj: Ilmoitus johtohenkilön liiketoimesta; hallituksen jäsen Wolfgang Büchele on myynyt 97 000 Kemiran osakettaTarkemmat tiedot liiketoimesta ovat alla.   IlmoitusvelvollinenNimi: Büchele, WolfgangAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: KEMIRALEI: 74370031Y7RK5H88CQ48Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 74370031Y7RK5H88CQ48_20200527092355_2____________________________________________Liiketoimen päivämäärä: 2020-05-26Kauppapaikka: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrumenttityyppi: OSAKEISIN: FI0009004824Liiketoimen luonne: LUOVUTUSLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 97 000 Yksikköhinta: 11,2049 EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 97 000 Keskihinta: 11,2049 EURKemira on globaali kemianyhtiö, joka palvelee asiakkaita runsaasti...

Continue reading

Meddelelse nr. 6, 2019/20

Halvårsrapportpr. 31. marts 2020Investeringsselskabet Luxor A/S’ bestyrelse har dags dato godkendt halvårsrapporten pr. 31. marts 2020.2. kvartal 2019/20:Basisindtjeningen udgør kr. 9,0 mio. (kr. 7,9 mio.). Koncernens resultat før skat udgør kr. 9,2 mio. (kr. 3,2 mio.)Kvartalets resultat før skat er kr. 0,2 mio. højere end basisindtjeningen primært som følge af regulering til dagsværdi af renteswaps.Halvåret 2019/20:Basisindtjeningen for halvåret udgør kr. 20,7 mio. (kr. 15,9 mio.). Koncernens resultat før skat for halvåret udgør kr. 27,1 mio. (kr. 8,4 mio.).Halvårets resultat før skat er kr. 6,4 mio. højere end basisindtjeningen primært som følge af:regulering til dagsværdi af renteswaps og realkreditlån med kr. 6,8 mio.regulering til dagsværdi af finansielle aktiver med kr. -0,4 mio.Forventet basisindtjening 2019/20:For regnskabsåret...

Continue reading

Lerøy Seafood Group ASA: ORDINARY GENERAL SHAREHOLDERS MEETING HELD

Ordinary General Meeting in Lerøy Seafood Group ASA was held today, Wednesday 27 May 2020. All items were resolved in accordance with the Boards Calling Notice and the Nomination Committee’s recommendations.The General Shareholders Meeting approved to distribute a dividend of NOK 1.50 per share. The dividend will be paid on 8 June 2020 and shall be paid to the shareholders who are registered shareholders of Lerøy Seafood Group ASA as of 27 May 2020.The shares in Lerøy Seafood Group ASA will be traded ex-dividend from and including 28 May 2020.The General Shareholders Meeting further approved to authorise the Board of Directors to pay additional up to NOK 0.80 per share as dividend before the end of the present year.  See translated attached copy of the minutes of the Ordinary General Shareholders Meeting in Lerøy Seafood Group ASA.This...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.